4D Molecular Therapeutics Inc Long-term Investment Intensity
4D Molecular Therapeutics Inc long-term investment intensity. 4D Molecular Therapeutics Inc (FDMT) has a Long-term Investment Intensity of 19.7% as of December 2025. Long-term investments of $111.38 Million represent 19.7% of total assets of $566.71 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. See FDMT net working capital ratio to evaluate short-term liquidity relative to the company's equity base.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Long-term Investment Intensity of 4D Molecular Therapeutics Inc (2021–2025)
Long-term investment intensity of 4D Molecular Therapeutics Inc from 2021 to 2025. This chart shows how 4D Molecular Therapeutics Inc's Long-term Investment Intensity has evolved across 5 annual periods from 2021 to 2025. As of December 2025, the intensity stands at 19.7%, reflecting long-term investments of $111.38 Million against total assets of $566.71 Million USD. See operational self-sufficiency of 4D Molecular Therapeutics Inc to measure how many days the company can operate on defensive assets alone.
4D Molecular Therapeutics Inc Long-term Investment Intensity by Year (2021–2025)
4D Molecular Therapeutics Inc long-term investment intensity by year from 2021 to 2025. The table below presents the year-by-year Long-term Investment Intensity for 4D Molecular Therapeutics Inc from 2021 to 2025, covering 5 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see FDMT total assets.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2025 | 19.7% | $111.38 Million | $566.71 Million | ▲ +5.3 pp |
| 2024 | 14.4% | $80.58 Million | $560.38 Million | ▲ +11.2 pp |
| 2023 | 3.2% | $10.95 Million | $339.89 Million | ▲ +1.3 pp |
| 2022 | 1.9% | $4.91 Million | $261.85 Million | ▼ -17.3 pp |
| 2021 | 19.1% | $67.65 Million | $353.49 Million | — |